Literature DB >> 17130251

C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis.

L S Mansfield1, J A Bell, D L Wilson, A J Murphy, H M Elsheikha, V A K Rathinam, B R Fierro, J E Linz, V B Young.   

Abstract

Campylobacter jejuni is a globally distributed cause of human food-borne enteritis and has been linked to chronic joint and neurological diseases. We hypothesized that C. jejuni 11168 colonizes the gastrointestinal tract of both C57BL/6 mice and congenic C57BL/6 interleukin-10-deficient (IL-10(-/-)) mice and that C57BL/6 IL-10(-/-) mice experience C. jejuni 11168-mediated clinical signs and pathology. Individually housed mice were challenged orally with C. jejuni 11168, and the course of infection was monitored by clinical examination, bacterial culture, C. jejuni-specific PCR, gross pathology, histopathology, immunohistochemistry, and anti-C. jejuni-specific serology. Ceca of C. jejuni 11168-infected mice were colonized at high rates: ceca of 50/50 wild-type mice and 168/170 IL-10(-/-) mice were colonized. In a range from 2 to 35 days after infection with C. jejuni 11168, C57BL/6 IL-10(-/-) mice developed severe typhlocolitis best evaluated at the ileocecocolic junction. Rates of colonization and enteritis did not differ between male and female mice. A dose-response experiment showed that as little as 10(6) CFU produced significant disease and pathological lesions similar to responses seen in humans. Immunohistochemical staining demonstrated C. jejuni antigens within gastrointestinal tissues of infected mice. Significant anti-C. jejuni plasma immunoglobulin levels developed by day 28 after infection in both wild-type and IL-10-deficient animals; antibodies were predominantly T-helper-cell 1 (Th1)-associated subtypes. These results indicate that the colonization of the mouse gastrointestinal tract by C. jejuni 11168 is necessary but not sufficient for the development of enteritis and that C57BL/6 IL-10(-/-) mice can serve as models for the study of C. jejuni enteritis in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130251      PMCID: PMC1828563          DOI: 10.1128/IAI.00833-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  68 in total

1.  Different invasion phenotypes of Campylobacter isolates in Caco-2 cell monolayers.

Authors:  Philippa Harvey; Thierry Battle; Steve Leach
Journal:  J Med Microbiol       Date:  1999-05       Impact factor: 2.472

2.  Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni.

Authors:  L H Lee; E Burg; S Baqar; A L Bourgeois; D H Burr; C P Ewing; T J Trust; P Guerry
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin-10-deficient mice.

Authors:  Li Zhang; Stephen J Danon; Martin Grehan; Vivian Chan; Adrian Lee; Hazel Mitchell
Journal:  Helicobacter       Date:  2005-06       Impact factor: 5.753

4.  The Campylobacter jejuni dccRS two-component system is required for optimal in vivo colonization but is dispensable for in vitro growth.

Authors:  Joanna K MacKichan; Erin C Gaynor; Christopher Chang; Shaun Cawthraw; Diane G Newell; Jeff F Miller; Stanley Falkow
Journal:  Mol Microbiol       Date:  2004-12       Impact factor: 3.501

5.  The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence.

Authors:  B N Fry; S Feng; Y Y Chen; D G Newell; P J Coloe; V Korolik
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.

Authors:  S Baqar; N D Pacheco; F M Rollwagen
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 8.  Campylobacter jejuni enterocolitis causing peritonitis, ileitis and intestinal obstruction.

Authors:  D J Perkins; G L Newstead
Journal:  Aust N Z J Surg       Date:  1994-01

9.  Cytolethal distending toxin (CDT)-negative Campylobacter jejuni strains and anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens.

Authors:  Manal Abuoun; Georgina Manning; Shaun A Cawthraw; Anne Ridley; If H Ahmed; Trudy M Wassenaar; Diane G Newell
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

10.  Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant.

Authors:  F M Rollwagen; N D Pacheco; J D Clements; O Pavlovskis; D M Rollins; R I Walker
Journal:  Vaccine       Date:  1993-10       Impact factor: 3.641

View more
  63 in total

Review 1.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

2.  Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis.

Authors:  B Otto; L-M Haag; A Fischer; R Plickert; A A Kühl; U B Göbel; M M Heimesaat; S Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 3.  Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection.

Authors:  Martin Stahl; Bruce A Vallance
Journal:  Gut Microbes       Date:  2015-04-01

4.  Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium.

Authors:  Sara M Dann; Christine Le; Barun K Choudhury; Houpu Liu; Omar Saldarriaga; Elaine M Hanson; Yingzi Cong; Lars Eckmann
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

Review 5.  Human Campylobacteriosis-A Serious Infectious Threat in a One Health Perspective.

Authors:  Markus M Heimesaat; Steffen Backert; Thomas Alter; Stefan Bereswill
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

6.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

7.  The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Authors:  Alexander C Maue; Krystle L Mohawk; David K Giles; Frédéric Poly; Cheryl P Ewing; Yuening Jiao; Ginyoung Lee; Zuchao Ma; Mario A Monteiro; Christina L Hill; Jason S Ferderber; Chad K Porter; M Stephen Trent; Patricia Guerry
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

8.  The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.

Authors:  Zhuo-Teng Yu; N Nanda Nanthakumar; David S Newburg
Journal:  J Nutr       Date:  2016-09-14       Impact factor: 4.798

9.  Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.

Authors:  Nadia Al-Banna; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

10.  Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

Authors:  Frédéric A Carvalho; Nicolas Barnich; Adeline Sivignon; Claude Darcha; Carlos H F Chan; Clifford P Stanners; Arlette Darfeuille-Michaud
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.